Passage BIO, Inc.

PASG

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001787297

SEC filings (opens in a new tab)

No open-market purchases or sales by Passage BIO, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.82M in total; no superinvestor holds it.

Q4 2022 vs. Q3 2022

How the institutions holding Passage BIO, Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022 All holders in Q3 2022

13F holders of PASG: Q3 2022 compared with Q4 2022
Measure	Q3 2022	Q4 2022	Change
Holders	76	68	−8
Shares	39.4M	37.4M	−2.04M (−5.2%)
Value	$49.3M	$51.6M	+$2.32M (+4.7%)

New holders (7)

Institutions that held Passage BIO, Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to PASG in Q4 2022
Institution	Shares	Value	% of portfolio
BML Capital Management, LLC	337,467	$465.7K	0.44%
Bailard, Inc.	156,900	$216.5K	0.01%
Marquette Asset Management, LLC	67,101	$92.6K	0.03%
Bank of Montreal	49,114	$70.2K	0.00%
Tri Locum Partners LP	22,661	$31.0K	0.01%
GWM Advisors LLC	90	$124	0.00%
Northwestern Mutual Wealth Management Co	20	$28	0.00%

Sold out (15)

Institutions that held Passage BIO, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of PASG in Q4 2022
Institution	Shares, Q3 2022	Value, Q3 2022
Deep Track Capital, LP	1,439,062	$1.80M
Highline Capital Management, L.P.	1,235,869	$1.54M
Woodline Partners LP	424,027	$530.0K
Marshall Wace, LLP	193,650	$242.0K
Algert Global LLC	76,360	$95.0K
Russell Investments Group, Ltd.	40,679	$50.0K
Qube Research & Technologies Ltd	30,129	$38.0K
LMR Partners LLP	13,229	$17.0K
Prelude Capital Management, LLC	12,400	$16.0K
Prudential Financial Inc	11,250	$14.0K
Quantbot Technologies LP	3,700	$4.00K
Point72 Hong Kong Ltd	3,400	$4.00K
Global Trust Asset Management, LLC	537	$1.00K
China Universal Asset Management Co., Ltd.	510	$1.00K
Daiwa Securities Group Inc.	185	$0